Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|February 13, 2014

Ecolab Rebrands Shield Medicare Division

Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.

Ecolab has changed the name of its Shield Medicare division to Ecolab Contamination Control. In conjunction with the change of name, a new website has been developed, which includes details of all products and services, along with information on the company’s sterile manufacturing processes. Since acquiring Shield Medicare, Ecolab has helped it to develop into a global organization with investments in a number of areas, including a new manufacturing facility, the company reports.

Source: Ecolab


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.